Argenx Maintains Market Leadership
Argenx, a biotechnology company listed on the stock market, has maintained its position as a market leader. This is evident from its recent RS rating increase to 84, a technical indicator that suggests strong price momentum.
The company’s stock price has demonstrated resilience, with a 52-week high of €658 reached on January 13, 2025. Key market data includes:
- 52-week high: €658 (January 13, 2025)
- Current stock price: €506.4
- 52-week low: €342.8
The current stock price remains above the 52-week low, indicating a stable market position.